Get started
Award

Molecular Neurobiology of Depression

Funding type: career_development
Funder scheme: K24
Start date: 1999-08-01
End date: 2006-07-31
Investigator: RICHARD CHARLES SHELTON
Institution: VANDERBILT UNIVERSITY
Funded outputs count: 37
Funder award ID: K24MH001741
OpenAlex ID: G4994101276
A re-examination of process–outcome relations in cognitive therapy for depression: Disaggregating within-patient and between-patient effects
2015 · Katherine E. Sasso, Daniel R. Strunk, et al. · Psychotherapy Research · 41
Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors
2015 · K A Garbett, A Vereczkei, et al. · Translational Psychiatry · 38
PDF
Coordinated Messenger RNA/MicroRNA Changes in Fibroblasts of Patients with Major Depression
2014 · Krassimira A. Garbett, Andrea Vereczkei, et al. · Biological Psychiatry · 69
Extreme response style and symptom return after depression treatment: The role of positive extreme responding.
2014 · Nicholas R. Forand, Robert J. DeRubeis · Journal of Consulting and Clinical Psychology · 28
Metabolic stress-induced microRNA and mRNA expression profiles of human fibroblasts
2013 · Sára Kálmán, Krassimira A. Garbett, et al. · Experimental Cell Research · 37
Pretreatment anxiety predicts patterns of change in cognitive behavioral therapy and medications for depression.
2013 · Nicholas R. Forand, Robert J. DeRubeis · Journal of Consulting and Clinical Psychology · 36
Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression
2010 · Richard C. Shelton, Andrew H. Miller · Progress in Neurobiology · 261
Antidepressant Drug Effects and Depression Severity
2010 · Jay C. Fournier, Robert J. DeRubeis, et al. · JAMA · 2,006
Therapist competence in cognitive therapy for depression: Predicting subsequent symptom change.
2010 · Daniel R. Strunk, Melissa A. Brotman, et al. · Journal of Consulting and Clinical Psychology · 128
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.
2009 · Jay C. Fournier, Robert J. DeRubeis, et al. · Journal of Consulting and Clinical Psychology · 340
Use of atypical antipsychotics for treatment-resistant major depressive disorder
2008 · George I. Papakostas, Richard C. Shelton · Current Psychiatry Reports · 19
Antidepressant medicationsv.cognitive therapy in people with depression with or without personality disorder
2008 · Jay C. Fournier, Robert J. DeRubeis, et al. · The British Journal of Psychiatry · 128
PDF
Augmentation of antidepressants with atypical antipsychotics for treatment‐resistant major depressive disorder
2008 · Richard C. Shelton, George I. Papakostas · Acta Psychiatrica Scandinavica · 112
Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression
2007 · M. K. Hahn, J. U. Blackford, et al. · Genes Brain & Behavior · 65
PDF
Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder
2007 · George I. Papakostas, Richard C. Shelton, et al. · The Journal of Clinical Psychiatry · 242
The Molecular Neurobiology of Depression
2007 · Richard C. Shelton · Psychiatric Clinics of North America · 243
A Randomized, Double-Blind, Crossover Trial of Modafinil on Mood
2007 · Indu Taneja, Kirsten Haman, et al. · Journal of Clinical Psychopharmacology · 54
Polymorphisms in the Regulatory Region of the Human Serotonin 5-HT 2A Receptor Gene (HTR2A) Influence Gene Expression
2006 · Regina L. Myers, David C. Airey, et al. · Biological Psychiatry · 135
Detection of an mRNA Polymorphism by Differential Display
2005 · Shan Liang, S. Paul Rossby, et al. · Humana Press eBooks · 27
Signal transduction abnormalities in melancholic depression
2005 · Demet Akin, D. Hal Manier, et al. · The International Journal of Neuropsychopharmacology · 64
PDF
Do venlafaxine XR and paroxetine equally influence negative and positive affect?
2005 · Gabriel S. Dichter, Andrew J. Tomarken, et al. · Journal of Affective Disorders · 30
Risperidone and Paroxetine Given Singly and in Combination for Bipolar Depression
2004 · Richard C. Shelton, Stephen M. Stahl · The Journal of Clinical Psychiatry · 99
Decreased Serotonin 5-HT2A Receptor-Stimulated Phosphoinositide Signaling in Fibroblasts from Melancholic Depressed Patients
2004 · Demet Akin, D Hal Manier, et al. · Neuropsychopharmacology · 43
Early‐ and late‐onset startle modulation in unipolar depression
2004 · Gabriel S. Dichter, Andrew J. Tomarken, et al. · Psychophysiology · 113
Differential Expression of Pentraxin 3 in Fibroblasts from Patients with Major Depression
2003 · Richard C Shelton, Shan Liang, et al. · Neuropsychopharmacology · 21
Year
Topic